What is INO? Inovio Pharmaceuticals (NASDAQ: INO) is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases.
News Inovio is partnering with the International Vaccine Institute and Seoul National University Hospital to run a phase 1/2 clinical trial of Inovio's COVID-19 vaccine INO-4800 in South Korea. The study, which is scheduled to begin later this month, will start with 40 participants and then expand into an additional 120 participants. For more information, click the link above.
My Thoughts For You Currently, the price is sitting on weekly support on the daily timeframe and looks to be holding so far. I expect to see this area tested a few times on the 4hr TF and if it holds then we can expect a move up towards the target area to test upper resistance and possibly blow past resistance. If this area does not hold then I expect to see a move down testing other support areas.
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.